Guy Le Page looks at Cygnus Metals and its big plans to build out a high-grade copper-gold opportunity through additional discoveries.

Canaccord's Tim Hoff saw Azure Minerals coming before it happened. He thinks Zambian copper junior Prospect has similar credentials.

A home-grown leader in sleep and neural analysis, Compumedics is tackling the burgeoning US home sleep testing market.

Strength in healthcare and financial stocks has kept the ASX on life support, retaining some gains to lift 0.21pc overall.

Meteoric Resources has been up to 36.3% higher after releasing a maiden resource estimate for the Bara do Pacu licence at its Caldeira REE project in Brazil.

Donald Trump considers the pinnacle of his ‘Make America Great Again’ pledge a US-made iPhone. This is an unlikely outcome and here's why.

ASX nudges up on US tariff hopes, but Bellevue Gold gets hammered after a capital raise, while HUB24 shines with record inflows.

Donald Trump again has raised the prospect of a new tariff on imported pharmaceuticals, reportedly pitched at a 25% rate.

Meteoric (ASX:MEI) has added tonnes to its Brazilian portfolio, making it one of the highest grade ionic clay rare earth deposits globally.

MPK (ASX:MPK) has started phase 2 diamond drilling at Ferké in Côte d’Ivoire testing extensions to high-grade mineralisation at Ouarigue.

Tony turns his attention to pivotal phase 3 trials and what mix of make or break biotechs you should have in your portfolio.

Climbing energy and gold stocks have lifted the ASX in early trading, boosting the bourse 0.3pc in the first hour.